Cell Cryopreservation Equipment Market Size & Outlook, 2026-2034

Cell Cryopreservation Equipment Market Overview

The global cell cryopreservation equipment market size is valued at USD 3.46 billion in 2025 and is estimated to reach USD 9.14 billion by 2034, growing at a CAGR of 11.44% during the forecast period. The consistent market growth is supported by the expanding use of cryopreserved cells across cell therapy manufacturing, biobanking programs, and regenerative medicine research worldwide. 

Key Market Trends & Insights

• North America held a dominant share of the global market, accounting for 41.14% in 2025.
• The Asia Pacific region is projected to grow at the fastest pace, with a CAGR of 13.44%.
• Based on Equipment, the liquid nitrogen supply tanks segment dominated the market with a revenue share of 40.12%.
• Based on the Application, the stem cells segment dominated the market with 31.23%.
• Based on End-Use, the bio-pharmaceutical & pharmaceutical companies segment dominated the market with a revenue share of 37.89%.
• The U.S. dominates the cell cryopreservation equipment market, valued at USD 1.16 billion in 2024 and reaching USD 1.29 billion in 2025.

Table: U.S. Cell Cryopreservation Equipment Market Size (USD Billion)

Source: Straits Research

Market Size & Forecast

• 2025 Market Size: USD 3.46 billion
• 2034 Projected Market Size: USD 9.14 billion
• CAGR (2026-2034): 11.44 %
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The cell cryopreservation equipment market comprises technologies and systems designed to preserve living cells at ultra-low temperatures to maintain viability, functionality, and genetic stability for extended storage and future use across research and clinical settings. By equipment, the market includes freezers that enable controlled rate and ultra-low temperature storage, incubators used during pre-freezing and post-thaw cell handling, and liquid nitrogen supply tanks that support long-term cryogenic storage conditions. By application, cell cryopreservation equipment is used for stem cells, reproductive cells, bioproduction cell lines, primary cells, and other specialized cell types involved in biomedical research, therapeutic development, fertility preservation, and industrial bioprocessing. By end use, the market serves biopharmaceutical and pharmaceutical companies, academic and research institutes, biobanks, IVF clinics, and other organizations engaged in cell-based research, sample storage, and clinical applications.

Latest Market Trends

Shift From Manual Cryogenic Handling To Automated and Controlled Rate Cryopreservation Systems

Cell cryopreservation practices are increasingly transitioning from manually operated freezing and storage approaches toward automated controlled-rate freezers and integrated liquid nitrogen management systems. Manual processes rely heavily on operator experience and can introduce variability in cooling profiles and storage conditions, which may affect post-thaw cell viability and functional recovery. Automated systems enable precise regulation of cooling rates, temperature uniformity, and alarm monitoring, supporting reproducible preservation outcomes across stem cells, reproductive cells, bioproduction cell lines, and primary cells. This shift aligns cryopreservation workflows with standardized laboratory and clinical protocols where consistency, traceability, and process documentation are central.

Shift From Centralized Cryostorage Facilities To Decentralized and Point-of-use Storage Models

The market is also moving from large centralized biobanks toward distributed cryopreservation setups within biopharmaceutical companies, IVF clinics, and regional research centers. On-site freezers and compact liquid nitrogen supply tanks allow faster sample access, reduced transport dependency, and closer integration with manufacturing or clinical workflows. This transition reflects changing operational models where localized storage supports flexible production schedules and timely cell retrieval for downstream use.

To get more insights about this report Download Free Sample Report

Market Driver

Expansion of Cell-based Therapies and Fertility Preservation Programs

Growth in regenerative medicine pipelines, cell therapy manufacturing, and assisted reproductive technologies is driving demand for cryopreservation equipment that supports long-term storage while maintaining cellular characteristics. Biopharmaceutical companies, biobanks, and IVF clinics increasingly invest in advanced freezing and storage systems to accommodate rising sample volumes and regulatory-aligned processes.

Market Restraint

High Capital and Operational Burden of Cryogenic Infrastructure

Ultra-low temperature freezers and liquid nitrogen systems require substantial upfront investment along with ongoing costs related to maintenance, safety compliance, and energy consumption. These factors can limit adoption among academic institutes and smaller laboratories, slowing equipment replacement cycles.

Market Opportunity

Growth of Regional Biobanks and Contract Cell Storage Services

Expansion of distributed biobanking networks and third-party cell storage providers creates opportunities for scalable cryopreservation equipment tailored for diverse cell types and storage durations. Demand is rising for modular systems that support standardized storage, inventory management, and regulatory readiness across geographically dispersed facilities, which further opens new avenues for manufacturers across the globe and hence expands the demand for the cell cryopreservation equipment market.

Regional Analysis

North America represents a leading region in the cell cryopreservation equipment market with a revenue share of 41.14%, supported by widespread deployment of advanced freezing and storage systems across biopharmaceutical companies, biobanks, and fertility centers. The region demonstrates high utilization of liquid nitrogen supply tanks and ultra-low temperature freezers within established cell banking and therapy development frameworks. Strong alignment between research institutions, clinical facilities, and commercial manufacturers supports consistent adoption of cryopreservation infrastructure.

In the U.S., market expansion is supported by extensive use of cryopreserved cells within cell therapy manufacturing and fertility preservation programs. Research hospitals and commercial laboratories continue to expand internal storage capacity, reinforcing the country’s dominant regional position.

Asia Pacific Market Insights

Asia Pacific registers the fastest growth of 13.44%, driven by the rapid expansion of laboratory infrastructure and the increasing establishment of regional biobanks and assisted reproduction centers. The growing deployment of freezers and liquid nitrogen systems across research institutes and clinical facilities supports higher equipment penetration.

In China, growth is supported by the expansion of large-scale cell storage facilities within hospital networks and research parks. Increasing investment in cryogenic storage capacity across public and private institutions sustains regional momentum.

Regional Market share (%) in 2025

Source: Straits Research

Europe Market Insights

Europe maintains steady adoption through the integration of cryopreservation equipment within academic research networks and healthcare-affiliated biobanks. Laboratories and clinical centers utilize standardized freezing and storage systems to support long-term preservation of diverse cell types. Coordinated research programs across countries contribute to consistent equipment uptake.

In Germany, growth is driven by expanding use of cryogenic storage within research institutes and pharmaceutical laboratories focused on cell-based studies. Academic centers and industrial laboratories increasingly deploy ultra-low temperature freezers and liquid nitrogen systems to preserve stem cells and primary cells for long-term research programs. Integration of cryostorage into translational research workflows supports steady equipment adoption.

Latin America Market Insights

Latin America experiences a gradual expansion as research institutions and fertility clinics increase adoption of cryopreservation equipment for cell and reproductive material storage. Universities and hospital laboratories invest in freezer systems to strengthen long-term sample preservation capabilities.

In Brazil, growth is reinforced by the expansion of academic research facilities and increased utilization of cryostorage equipment within public healthcare laboratories, as universities and government-funded research centers continue to strengthen their capabilities in cell-based research and long-term biological sample preservation. Public hospitals and affiliated laboratories are incorporating ultra-low temperature freezers and liquid nitrogen storage systems to support preservation of primary cells, stem cells, and reproductive cells for research programs and clinical studies. Ongoing investments in laboratory modernization and collaborative research initiatives between academic institutions and healthcare organizations further support the broader adoption of cryopreservation equipment across the country.

Middle East and Africa Market Insights

The Middle East and Africa region advances through the development of laboratory infrastructure and the growing incorporation of cryopreservation systems within research hospitals and specialized clinics. Adoption of freezing and liquid nitrogen storage equipment supports preservation of cells for research and clinical use.

In the United Arab Emirates, market momentum is supported by the deployment of cryogenic storage infrastructure within research centers and advanced healthcare facilities, strengthening the country’s regional presence.

Equipment Insights

Liquid nitrogen supply tanks dominated the equipment segment with a share of 40.12%, supported by their central role in long-term cell storage across biobanks, biopharmaceutical facilities, and IVF clinics. These systems provide stable ultra-low temperature environments required for preserving stem cells, reproductive cells, and primary cells over extended durations, making them integral to large-scale storage infrastructures.

Freezers are anticipated to register the fastest growth at 12.56%, driven by increasing adoption of controlled-rate and ultra-low temperature freezers within research laboratories and cell manufacturing facilities. Rising preference for on-site storage and precise temperature control accelerates demand for advanced freezer systems.

Application Insights

Stem cells dominated the application segment with a share of 31.23%, reflecting extensive cryopreservation of hematopoietic, mesenchymal, and pluripotent stem cells for therapeutic development, regenerative medicine research, and long-term banking. High sample volumes and repeat preservation cycles sustain demand for specialized cryogenic equipment in this segment.

Reproductive cells are projected to grow at the fastest rate of 12.32%, supported by expanding assisted reproductive procedures and fertility preservation programs. Increased cryostorage of oocytes and sperm within clinical settings contributes to higher adoption of dedicated cryopreservation systems.

End Use Insights

Biopharmaceutical and pharmaceutical companies led the end-use segment with a share of 37.89%, driven by active cell therapy pipelines and internal cell banking activities that require integrated freezing and storage infrastructure. These organizations deploy cryopreservation equipment to support process continuity across development and manufacturing stages.

Biobanks are expected to witness the fastest growth at 12.89%, as expansion of population-based sample repositories and disease-focused cell banks increases demand for scalable and monitored cryogenic storage solutions.

End Use Market share (%) in 2025

Source: Straits Research

Competitive Landscape

The global cell cryopreservation equipment market is moderately fragmented, with a combination of established life science equipment manufacturers and specialized cryogenic storage providers operating across research, clinical, and biomanufacturing environments. Market participants compete through the expansion of freezer portfolios, the development of liquid nitrogen storage systems, and the integration of monitoring and safety features aligned with laboratory and clinical workflows. Companies strengthen their market presence through global distribution networks, service support capabilities, and long-term supply relationships with biopharmaceutical companies, biobanks, and fertility clinics. Ongoing focus on scalable storage capacity, temperature stability, and compatibility with diverse cell types supports competitive differentiation.

Chart Industries Inc.: An Emerging Market Player

Chart Industries Inc. holds a notable position in the cell cryopreservation equipment market through its portfolio of liquid nitrogen supply tanks and cryogenic storage systems used across biobanks, research institutes, and clinical facilities. The company supports long-term preservation of stem cells, reproductive cells, and primary cells by providing storage solutions designed for stable ultra-low temperature conditions. Its focus on scalable tank capacities and engineered cryogenic systems enables adoption across centralized and distributed storage environments. Chart Industries continues to expand its presence by aligning cryogenic infrastructure offerings with growing cell banking and life science research activities.

List of key players in Cell Cryopreservation Equipment Market

1. Thermo Fisher Scientific Inc.
2. Chart Industries, Inc.
3. PHC Holdings Corporation
4. Eppendorf SE
5. Merck KGaA
6. Panasonic Corporation
7. Azenta, Inc.
8. Cryoport, Inc.
9. BioLife Solutions, Inc.
10. Taylor-Wharton Cryogenics, LLC
11. Worthington Industries, Inc.
12. Helmer Scientific Inc.
13. VWR International, LLC
14. Haier Biomedical
15. Linde plc
16. Air Liquide S.A.
17. ThermoGenesis Holdings, Inc.
18. Others

To get more findings about this report Download Market Share

Strategic Initiatives

• April 2024: Thermo Fisher Scientific Inc. launched TSX Universal Series ULT freezers, which are certified ENERGY STAR and provide improved performance, quicker recovery, and 33% energy savings for environmentally friendly laboratory operations.